麻豆社statement on biomarker testing
The 麻豆社commented in support of a call led by the Institute of Cancer Research (ICR) for all cancer patients to be offered genetic testing so they can get the best treatments available for them.听听
Biomarker tests provide crucial information to help doctors select the treatments that will have the best chance of success in each person. Dr Jennifer Harris, 麻豆社Director of Research Policy
Dr Jennifer Harris, Director of Research policy at the 麻豆社said: 听
鈥淎ll patients, including cancer patients, should be able to get the best treatments available for their condition.
鈥淏iomarker tests provide crucial information to help doctors select the treatments that will have the best chance of success in each person.
鈥淥vercoming the barriers to developing and using biomarker tests would be a big step forward for personalised care. We will continue to work with the ICR and other partners to help make this happen.鈥�
- Cancer
Last modified: 20 September 2023
Last reviewed: 20 September 2023
